{"id":"https://openalex.org/W7053354550","doi":null,"title":"Use of trans-complementation method to determine the effects of various ftsl mutations on \u03b2-lactamase-negative ampicillin-resistant (BLNAR) Haemophilus influenzae strains","display_name":"Use of trans-complementation method to determine the effects of various ftsl mutations on \u03b2-lactamase-negative ampicillin-resistant (BLNAR) Haemophilus influenzae strains","publication_year":2025,"publication_date":"2025-02-06","ids":{"openalex":"https://openalex.org/W7053354550"},"language":"en","primary_location":{"id":"pmh:oai:figshare.com:article/27412740","doi":null,"is_oa":false,"landing_page_url":"https://figshare.com/articles/journal_contribution/Use_of_trans-complementation_method_to_determine_the_effects_of_various_i_ftsl_i_mutations_on_-lactamase-negative_ampicillin-resistant_BLNAR_i_Haemophilus_influenzae_i_strains/27412740","pdf_url":null,"source":{"id":"https://openalex.org/S4377196282","display_name":"Figshare","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I4210132348","host_organization_name":"Figshare (United Kingdom)","host_organization_lineage":["https://openalex.org/I4210132348"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"submittedVersion","is_accepted":false,"is_published":false,"raw_source_name":null,"raw_type":"Text"},"volume":null,"type":"article","indexed_in":[],"open_access":{"is_oa":false,"oa_status":"closed","oa_url":null,"any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5076748554","display_name":"Melis Yal\u00e7\u0131n","orcid":"https://orcid.org/0000-0002-6336-4018","observed_orcids":["https://orcid.org/0000-0002-6336-4018"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Melis Yalcin (20007411)","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5034050722","display_name":"Stephen G. Tristram","orcid":"https://orcid.org/0000-0002-8485-0322","observed_orcids":["https://orcid.org/0000-0002-8485-0322"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Stephen Tristram (14751343)","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"last","author":{"id":"https://openalex.org/A5019804395","display_name":"B\u00fclent Bozdo\u011fan","orcid":"https://orcid.org/0000-0003-2469-9728","observed_orcids":["https://orcid.org/0000-0003-2469-9728","https://orcid.org/0000-0001-8846-7649"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Bulent Bozdogan (11896881)","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]}],"institutions":[],"countries_distinct_count":0,"institutions_distinct_count":0,"corresponding_author_ids":[],"corresponding_institution_ids":[],"apc_list":null,"apc_paid":null,"fwci":0.0,"has_fulltext":false,"cited_by_count":0,"citation_normalized_percentile":{"value":0.26933662,"is_in_top_1_percent":false,"is_in_top_10_percent":false},"cited_by_percentile_year":null,"biblio":{"volume":null,"issue":null,"first_page":null,"last_page":null},"is_retracted":false,"is_paratext":false,"is_xpac":true,"primary_topic":{"id":"https://openalex.org/T10147","display_name":"Antibiotic Resistance in Bacteria","score":0.9951000213623047,"subfield":{"id":"https://openalex.org/subfields/1313","display_name":"Molecular Medicine"},"field":{"id":"https://openalex.org/fields/13","display_name":"Biochemistry, Genetics and Molecular Biology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},"topics":[{"id":"https://openalex.org/T10147","display_name":"Antibiotic Resistance in Bacteria","score":0.9951000213623047,"subfield":{"id":"https://openalex.org/subfields/1313","display_name":"Molecular Medicine"},"field":{"id":"https://openalex.org/fields/13","display_name":"Biochemistry, Genetics and Molecular Biology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},{"id":"https://openalex.org/T10195","display_name":"Antimicrobial Resistance in Staphylococcus","score":0.0008999999845400453,"subfield":{"id":"https://openalex.org/subfields/2725","display_name":"Infectious Diseases"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10120","display_name":"Bacterial Genetics and Biotechnology","score":0.000699999975040555,"subfield":{"id":"https://openalex.org/subfields/1311","display_name":"Genetics"},"field":{"id":"https://openalex.org/fields/13","display_name":"Biochemistry, Genetics and Molecular Biology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/haemophilus-influenzae","display_name":"Haemophilus influenzae","score":0.9929999709129333},{"id":"https://openalex.org/keywords/beta-lactam-resistance","display_name":"beta-lactam resistance","score":0.8080000281333923},{"id":"https://openalex.org/keywords/penicillin-binding-protein-3","display_name":"penicillin-binding protein 3","score":0.9549999833106995},{"id":"https://openalex.org/keywords/trans-complementation","display_name":"trans-complementation","score":0.9620000123977661},{"id":"https://openalex.org/keywords/ampicillin-resistance","display_name":"ampicillin resistance","score":0.8700000047683716},{"id":"https://openalex.org/keywords/cefotaxime-resistance","display_name":"cefotaxime resistance","score":0.8830000162124634},{"id":"https://openalex.org/keywords/antibiotic-susceptibility","display_name":"antibiotic susceptibility","score":0.5699999928474426}],"concepts":[{"id":"https://openalex.org/C2776925733","wikidata":"https://www.wikidata.org/wiki/Q1141979","display_name":"Haemophilus influenzae","level":3,"score":0.8806999921798706},{"id":"https://openalex.org/C2778719061","wikidata":"https://www.wikidata.org/wiki/Q417968","display_name":"Cefotaxime","level":3,"score":0.7251999974250793},{"id":"https://openalex.org/C89423630","wikidata":"https://www.wikidata.org/wiki/Q7193","display_name":"Microbiology","level":1,"score":0.6410999894142151},{"id":"https://openalex.org/C86803240","wikidata":"https://www.wikidata.org/wiki/Q420","display_name":"Biology","level":0,"score":0.6121000051498413},{"id":"https://openalex.org/C2776021129","wikidata":"https://www.wikidata.org/wiki/Q244150","display_name":"Ampicillin","level":3,"score":0.5857999920845032},{"id":"https://openalex.org/C183641309","wikidata":"https://www.wikidata.org/wiki/Q306264","display_name":"Amp resistance","level":4,"score":0.5583000183105469},{"id":"https://openalex.org/C204241405","wikidata":"https://www.wikidata.org/wiki/Q461499","display_name":"Transformation (genetics)","level":3,"score":0.5418999791145325},{"id":"https://openalex.org/C104317684","wikidata":"https://www.wikidata.org/wiki/Q7187","display_name":"Gene","level":2,"score":0.531000018119812},{"id":"https://openalex.org/C22744801","wikidata":"https://www.wikidata.org/wiki/Q172778","display_name":"Plasmid","level":3,"score":0.5270000100135803},{"id":"https://openalex.org/C501593827","wikidata":"https://www.wikidata.org/wiki/Q12187","display_name":"Antibiotics","level":2,"score":0.4893999993801117},{"id":"https://openalex.org/C501734568","wikidata":"https://www.wikidata.org/wiki/Q42918","display_name":"Mutation","level":3,"score":0.45899999141693115},{"id":"https://openalex.org/C54355233","wikidata":"https://www.wikidata.org/wiki/Q7162","display_name":"Genetics","level":1,"score":0.45260000228881836},{"id":"https://openalex.org/C143065580","wikidata":"https://www.wikidata.org/wiki/Q3285695","display_name":"Mutant","level":3,"score":0.44179999828338623},{"id":"https://openalex.org/C127716648","wikidata":"https://www.wikidata.org/wiki/Q104053","display_name":"Phenotype","level":3,"score":0.43639999628067017},{"id":"https://openalex.org/C2777154767","wikidata":"https://www.wikidata.org/wiki/Q142666","display_name":"Pasteurellaceae","level":4,"score":0.43050000071525574},{"id":"https://openalex.org/C2778022156","wikidata":"https://www.wikidata.org/wiki/Q576145","display_name":"Strain (injury)","level":2,"score":0.41929998993873596},{"id":"https://openalex.org/C64778159","wikidata":"https://www.wikidata.org/wiki/Q271021","display_name":"Cephalosporin","level":3,"score":0.34769999980926514},{"id":"https://openalex.org/C3019249092","wikidata":"https://www.wikidata.org/wiki/Q274493","display_name":"Antibacterial agent","level":3,"score":0.3018999993801117},{"id":"https://openalex.org/C523546767","wikidata":"https://www.wikidata.org/wiki/Q10876","display_name":"Bacteria","level":2,"score":0.3010999858379364},{"id":"https://openalex.org/C153911025","wikidata":"https://www.wikidata.org/wiki/Q7202","display_name":"Molecular biology","level":1,"score":0.2799000144004822},{"id":"https://openalex.org/C94665300","wikidata":"https://www.wikidata.org/wiki/Q63391344","display_name":"Antibiotic resistance","level":3,"score":0.2752000093460083},{"id":"https://openalex.org/C176947019","wikidata":"https://www.wikidata.org/wiki/Q597889","display_name":"Minimum inhibitory concentration","level":3,"score":0.26930001378059387},{"id":"https://openalex.org/C180223184","wikidata":"https://www.wikidata.org/wiki/Q4839986","display_name":"Bacterial genetics","level":4,"score":0.2612000107765198}],"mesh":[],"locations_count":1,"locations":[{"id":"pmh:oai:figshare.com:article/27412740","doi":null,"is_oa":false,"landing_page_url":"https://figshare.com/articles/journal_contribution/Use_of_trans-complementation_method_to_determine_the_effects_of_various_i_ftsl_i_mutations_on_-lactamase-negative_ampicillin-resistant_BLNAR_i_Haemophilus_influenzae_i_strains/27412740","pdf_url":null,"source":{"id":"https://openalex.org/S4377196282","display_name":"Figshare","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I4210132348","host_organization_name":"Figshare (United Kingdom)","host_organization_lineage":["https://openalex.org/I4210132348"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"submittedVersion","is_accepted":false,"is_published":false,"raw_source_name":null,"raw_type":"Text"}],"best_oa_location":null,"sustainable_development_goals":[{"display_name":"Good health and well-being","score":0.8371999859809875,"id":"https://metadata.un.org/sdg/3"}],"sustainable_development_goals_aurora":[{"display_name":"Good health and well-being","score":0.5012388825416565,"id":"https://metadata.un.org/sdg/3"}],"study_designs":[],"awards":[],"funders":[],"has_content":{"pdf":false,"grobid_xml":false},"content_urls":null,"referenced_works_count":0,"referenced_works":[],"related_works":[],"abstract_inverted_index":{"Haemophilus":[0],"influenzae":[1,25,71],"is":[2,29],"a":[3,93,176],"causative":[4],"agent":[5],"of":[6,20,34,157,165,182],"serious":[7],"infections,":[8],"especially":[9],"among":[10],"children.":[11],"\u03b2-lactam":[12,27,68,102,184],"antibiotics":[13],"are":[14],"commonly":[15],"used":[16,84],"for":[17,53,61,131,139,150],"the":[18,32,40,155,158,162,180],"treatment":[19],"these":[21,166],"infections.":[22],"Among":[23],"H.":[24,70,187],"isolates,":[26],"resistance":[28],"due":[30],"to":[31,37,78,85],"presence":[33],"\u03b2-lactamase,":[35],"or":[36],"mutations":[38],"in":[39,65,75,161,179,186],"ftsI":[41,58,98,135],"gene":[42,59],"that":[43,123,172],"generate":[44],"altered":[45],"PBP3":[46,62,159],"(penicillin-binding":[47],"protein":[48],"3)":[49],"with":[50,96,115],"reduced":[51,101],"affinity":[52],"\u03b2-lactams":[54],"(BLNAR-\u03b2-lactamase-negative,":[55],"ampicillin-resistant).":[56],"Wild-type":[57],"encoding":[60],"was":[63,82],"amplified":[64],"whole":[66],"from":[67],"susceptible":[69,90],"Rd":[72],"and":[73,92,105,117,148,152],"cloned":[74],"pLS88":[76,116],"plasmid":[77],"obtain":[79],"pADUTAS17,":[80],"which":[81],"then":[83],"transform":[86],"known":[87],"BLNAR":[88,141,163],"strains,":[89,91],"strain":[94],"(CF55)":[95],"wild-type":[97,134],"but":[99],"unexplained":[100],"susceptibility.":[103],"Ampicillin":[104],"cefotaxime":[106],"MICs":[107],"(minimum":[108],"inhibitory":[109],"concentration)":[110],"were":[111,126],"determined":[112],"after":[113],"transformation":[114],"pADUTAS17":[118],"plasmids.":[119],"The":[120,168],"results":[121],"showed":[122,143,171],"antibiotic":[124],"susceptibilities":[125],"not":[127],"affected":[128],"by":[129],"trans-complementation":[130,138,173],"isolates":[132],"carrying":[133],"gene.":[136],"However,":[137],"all":[140],"strains":[142],"decreases":[144],"between":[145],"-":[146],"0.957":[147],"0.5-fold":[149],"ampicillin":[151],"cefotaxime,":[153],"confirming":[154],"role":[156],"substitutions":[160],"phenotype":[164],"isolates.":[167],"first":[169],"article":[170],"might":[174],"be":[175],"useful":[177],"tool":[178],"investigation":[181],"decreased":[183],"susceptibility":[185],"influenzae.":[188]},"counts_by_year":[],"updated_date":"2026-10-14T16:39:01.820549","created_date":"2025-10-10T00:00:00"}
